What is the current stock price of Lumos Pharma, Inc. (LUMO)?

As of the latest market data, Lumos Pharma, Inc. (LUMO) is trading at $4.34. The stock has seen a loss of 0.00% today.

Does Lumos Pharma, Inc. (LUMO) pay a dividend?

Based on current data, Lumos Pharma, Inc. does not have a confirmed active dividend policy.

What is the market cap of Lumos Pharma, Inc.?

The current market capitalization of Lumos Pharma, Inc. (LUMO) is approximately unavailable.

LUMO

Lumos Pharma, Inc.·Healthcare

4.34

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $1.3752W H: $4.58

Company Profile

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2011-11-11

Beta

0.33

Websitewww.lumos-pharma.com↗